Gene · 3145
Papers3,427
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 3,427
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sulfated carboxymethyl cellulose and carboxymethyl κ-carrageenan immobilization on 3D-printed poly-ε-caprolactone scaffolds differentially promote pre-osteoblast proliferation and osteogenic activity. | Front Bioeng Biotechnol | 2022 | 36213076 | PubTator, text mining | PubMed |
| Nanoformulation of Tetrapyrroles Derivatives in Photodynamic Therapy: A Focus on Bacteriochlorin. | Evid Based Complement Alternat Med | 2022 | 36212948 | PubTator, text mining | PubMed |
| 5-ALA-guided tumor resection during awake speech mapping in gliomas located in eloquent speech areas: Single-center experience. | Front Oncol | 2022 | 36212421 | PubTator, text mining | PubMed |
| The impact of heme biosynthesis regulation on glioma aggressiveness: Correlations with diagnostic molecular markers. | Front Mol Neurosci | 2022 | 36187350 | PubTator, text mining | PubMed |
| Characterizing inflammatory markers in highly aggressive soft tissue sarcomas. | Medicine (Baltimore) | 2022 | 36181081 | PubTator, text mining | PubMed |
| Identification of stable housekeeping genes for induced pluripotent stem cells and -derived endothelial cells for drug testing. | Sci Rep | 2022 | 36171445 | PubTator, text mining | PubMed |
| Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy. | J Immunother Cancer | 2022 | 36171009 | PubTator, text mining | PubMed |
| Unique and shared systemic biomarkers for emphysema in Alpha-1 Antitrypsin deficiency and chronic obstructive pulmonary disease. | EBioMedicine | 2022 | 36155958 | PubTator, text mining | PubMed |
| Lipopolysaccharide Inhibits Autophagy and Promotes Inflammatory Responses via p38 MAPK-Induced Proteasomal Degradation of Atg13 in Hepatic Stellate Cells. | Mediators Inflamm | 2022 | 36148140 | PubTator, text mining | PubMed |
| Multi-omics data integration for hepatocellular carcinoma subtyping with multi-kernel learning. | Front Genet | 2022 | 36147508 | PubTator, text mining | PubMed |
| Iron Metabolism in the Disorders of Heme Biosynthesis. | Metabolites | 2022 | 36144223 | PubTator, text mining | PubMed |
| Identification of Human Global, Tissue and Within-Tissue Cell-Specific Stably Expressed Genes at Single-Cell Resolution. | Int J Mol Sci | 2022 | 36142130 | PubTator, text mining | PubMed |
| Causes and Pathophysiology of Acquired Sideroblastic Anemia. | Genes (Basel) | 2022 | 36140729 | PubTator, text mining | PubMed |
| Comparative Analysis of Co-Cultured Amniotic Cell-Conditioned Media with Cell-Free Amniotic Fluid Reveals Differential Effects on Epithelial-Mesenchymal Transition and Myofibroblast Activation. | Biomedicines | 2022 | 36140291 | PubTator, text mining | PubMed |
| Long-term Remission of Acute Intermittent Porphyria Treated with Gonadotropin-Releasing Hormone Analogues and Estrogen: a Case Report. | Clin Lab | 2022 | 36125144 | PubTator, text mining | PubMed |
| Identifying stable reference genes in polyethene glycol precipitated urinary extracellular vesicles for RT-qPCR-based gene expression studies in renal graft dysfunction patients. | Transpl Immunol | 2022 | 36122652 | PubTator, text mining | PubMed |
| Key signal transduction pathways and crosstalk in cancer: Biological and therapeutic opportunities. | Transl Oncol | 2022 | 36122506 | PubTator, text mining | PubMed |
| Characterisation of a common hotspot variant in acute intermittent porphyria sheds light on the mechanism of hydroxymethylbilane synthase function. | FEBS Open Bio | 2022 | 36115019 | PubTator, text mining | PubMed |
| Targeting cancer cachexia: Molecular mechanisms and clinical study. | MedComm (2020) | 2022 | 36105371 | PubTator, text mining | PubMed |
| Whole-exome sequencing reveals a comprehensive germline mutation landscape and identifies twelve novel predisposition genes in Chinese prostate cancer patients. | PLoS Genet | 2022 | 36095024 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3145/papers?page=22